Myeloperoxidase-generated oxidants and atherosclerosis

Free Radical Biology and Medicine

Volumn 28, Issue 12, 2000, Pages 1717-1725

  Podrez, Eugene A ^a   Abu Soud, Husam M ^a   Hazen, Stanley L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Chlorination; Free radicals; Inflammation; Lipid peroxidation; Myeloperoxidase; Nitration

Indexed keywords

FREE RADICAL; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; OXIDIZING AGENT;

ATHEROSCLEROSIS; CHLORINATION; CHRONIC INFLAMMATION; HOST RESISTANCE; HUMAN; INFLAMMATORY DISEASE; LIPID PEROXIDATION; NITRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0034659164     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00229-X     Document Type: Article

References (95)

1. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
2. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis basic mechanisms. Oxidation, inflammation, and genetics . Circulation. 91:1995;2488-2496.
3. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low density lipoprotein hypothesis . Atherosclerosis. 141:1998;1-15.
4. Chisolm G.M. III, Hazen S.L., Fox P.L., Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 274:1999;25959-25962.
5. Steinbrecher U.P. Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta. 1436:1999;279-298.
6. Yla-Herttuala S. Oxidized LDL and atherogenesis. Ann. NY Acad. Sci. 874:1999;134-137.
7. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437-444.
8. Nauseef W.M., Malech H.L. Analysis of the peptide subunits of human neutrophil myeloperoxidase. Blood. 67:1986;1504-1507.
9. Hurst, J. K. Myeloperoxidase-active site structure and catalytic machanisms. In: Everse J.; Everse K.; Grisham M. B., eds. Peroxidases in chemistry and biology 1st ed. Boca Raton: CRC Press; 1991:37-62.
10. Klebanoff S.J., Clark R.A. The neutrophil functions and clinical disorders . 1978;Elsevier Scientific Publishing Co, Amsterdam.
11. Babior B.M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:1978;659-668.
12. Harrison J.E., Schultz J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1976;1371-1374.
13. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320:1989;365-376.
14. Heinecke J.W., Li W., Francis G.A., Goldstein J.A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91:1993;2866-2872.
15. Hazen S.L., Hsu F.F., Mueller D.M., Crowley J.R., Heinecke J.W. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98:1996;1283-1289.
16. Kettle A.J., Winterbourn C.C. Myeloperoxidase A key regulator of neutrophil oxidant production . Redox. Rep. 3:1997;3-15.
17. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391:1998;393-397.
18. Hazen S.L., Zhang R., Shen Z., Wu W., Podrez E.A., MacPherson J.C., Schmitt D., Mitra S.N., Mukhopadhyay C., Chen Y., Cohen P.A., Hoff H.F., Abu-Soud H.M. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo . Circ. Res. 85:1999;950-958.
19. Abu-Soud H.M., Hazen S.L. Nitric oxide modulates the catalytic activity of myeloperoxidase. J. Biol. Chem. 275:2000;5425-5430.
20. Foote C.S., Goyne T.E., Lehrer R.I. Assessment of chlorination by human neutrophils. Nature. 301:1983;715-726.
21. Weiss S.J., Klein R., Slivka A., Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70:1982;598-607.
22. Zeng J., Fenna R.E. X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J. Mol. Biol. 226:1992;185-207.
23. Tien M. Myeloperoxidase-catalyzed oxidation of tyrosine. Arch. Biochem. Biophys. 367:1999;61-66.
24. van der Vliet, A.; Eiserich J.P., Halliwell B., Cross C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272:1997;7617-7625.
25. Heinecke J.W., Li W., Daehnke H.L. III, Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268:1993;4069-4077.
26. Marquez L.A., Dunford H.B., Van Wart H. Kinetic studies on the reaction of compound II of myeloperoxidase with ascorbic acid. Role of ascorbic acid in myeloperoxidase function. J. Biol. Chem. 265:1990;5666-5670.
27. Maehly H.C. Myeloperoxidase. Methods Enzymol. 2:1955;798-801.
28. Metodiewa D., Dunford H.B. The role of myeloperoxidase in the oxidation of biologically active polyhydroxyphenols (substituted catechols). Eur. J. Biochem. 193:1990;445-448.
29. Klebanoff S.J. Estrogen binding by leukocytes during phagocytosis. J. Exp. Med. 145:1977;983-998.
30. Svensson B.E. Involvement of cysteine, serotonin and their analogues in peroxidase-oxidase reactions. Chem. Biol. Interact. 70:1989;305-321.
31. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:1994;20394-20400.
32. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103:1999;1547-1560.
33. Schmitt D., Shen Z., Zhang R., Colless S.M., Wu W., Chen Y., Chisolm G.M., Hazen S.L. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalyst for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry. 38:1999;16904-16915.
34. O'Brien P.J. Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics the reactivity of these radicals with GSH, DNA, and unsaturated lipid . Free Radic. Biol. Med. 4:1988;169-183.
35. Kettle A.J., Robertson I.G., Palmer B.D., Anderson R.F., Patel K.B., Winterbourn C.C. Oxidative metabolism of amsacrine by the neutrophil enzyme myeloperoxidase. Biochem. Pharmacol. 44:1992;1731-1738.
36. Kettle A.J., Winterbourn C.C. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J. Biol. Chem. 267:1992;8319-8324.
37. Panousis C., Kettle A.J., Phillips D.R. Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase. Biochem. Pharmacol. 48:1994;2223-2230.
38. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:1990;535-560.
39. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide physiology, pathophysiology, and pharmacology . Pharmacol. Rev. 43:1991;109-142.
40. Cooper C.E. Nitric oxide and iron proteins. Biochim. Biophys. Acta. 1411:1999;290-309.
41. Evans T.J., Buttery L.D., Carpenter A., Springall D.R., Polak J.M., Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA. 93:1996;9553-9558.
42. Abu-Soud, H. M.; Hazen, S. L. Nitric oxide is a physiological substrate for mammalian animal peroxidases. Submitted; 2000.
43. Chisolm G.M., Ma G., Irwin K.C., Martin L.L., Gunderson K.G., Linberg L.F., Morel D.W., DiCorleto P.E. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;11452-11456.
44. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
45. Hazen S.L., Heinecke J.W. 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075-2081.
46. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:1997;1433-1436.
47. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.
48. Hazen S.L., Hsu F.F., Gaut J.P., Crowley J.R., Heinecke J.W. Modification of proteins and lipids by myeloperoxidase. Methods Enzymol. 300:1999;88-105.
49. Heinecke J.W. Mass spectrometric quantification of amino acid oxidation products in proteins insights into pathways that promote LDL oxidation in the human artery wall . FASEB J. 13:1999;1113-1120.
50. Davies M.T., Fu S., Wang H., Dean R.T. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic. Biol. Med. 27:1999;1151-1163.
51. Weiss S.J., Test S.T., Eckmann C.M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science. 234:1986;200-203.
52. Hazen S.L., Crowley J.R., Mueller D.M., Heinecke J.W. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation . Free Radic. Biol. Med. 23:1997;909-916.
53. Weil I., Morris J.C. Kinetic studies on the chloramines. I. The rates of formation of monochloramine, N-chlormethylamine and N-chlordimethylamine. J. Am. Chem. Soc. 71:1949;1664-1671.
54. Thomas E.L., Jefferson M.M., Grisham M.B. Myeloperoxidase-catalyzed incorporation of amines into proteins role of hypochlorous acid and dichloramines . Biochemistry. 21:1982;6299-6308.
55. Winterbourn C.C., van den Berg J.J., Roitman E., Kuypers F.A. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296:1992;547-555.
56. White G.C. Chemistry of chlorination. Handbook of chlorination. 1972;182-227 Van Nostrand Reinhold, New York.
57. Kettle A.J., Winterbourn C.C. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 233:1994;502-512.
58. Albrich J.M., McCarthy C.A., Hurst J.K. Biological reactivity of hypochlorous acid Implications for microbicidal mechanisms of leukocyte myeloperoxidase . Proc. Natl. Acad. Sci. USA. 78:1981;210-214.
59. Krinsky N.I. Singlet excited oxygen as a mediator of the antibacterial action of leukocytes. Science. 186:1974;363-365.
60. Candeias L.P., Patel K.B., Stratford M.R., Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett. 333:1993;151-153.
61. Heinecke J.W., Li W., Mueller D.M., Bohrer A., Turk J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system potential markers for lipoproteins oxidatively damaged by phagocytes . Biochemistry. 33:1994;10127-10136.
62. Hazen S.L., Hsu F.F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271:1996;23080-23088.
63. Kettle A.J. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett. 379:1996;103-106.
64. Hazell L.J., van den Berg J.J., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:1994;297-304.
65. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165-172.
66. Panasenko O.M., Briviba K., Klotz L.O., Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch. Biochem. Biophys. 343:1997;254-259.
67. Hazen S.L., Hsu F.F., Heinecke J.W. p-hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes. A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J. Biol. Chem. 271:1996;1861-1867.
68. Hazen S.L., Hsu F.F., d'Avignon A., Heinecke J.W. Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes a pathway for aldehyde generation at sites of inflammation . Biochemistry. 37:1998;6864-6873.
69. Hazen S.L., d'Avignon A., Anderson M.M., Hsu F.F., Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 273:1998;4997-5005.
70. Anderson M.M., Hazen S.L., Hsu F.F., Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99:1997;424-432.
71. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Noguchi N., Niki E., Osawa T. Protein-bound acrolein potential markers for oxidative stress . Proc. Natl. Acad. Sci. USA. 95:1998;4882-4887.
72. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
73. 2-chloride system of phagocytes, covalently modifies ε-amino groups of protein lysine residues. J. Biol. Chem. 272:1997;16990-16998.
74. Hazen S.L., Heller J., Hsu F.F., d'Avignon A., Heinecke J.W. Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine. Chem. Res. Toxicol. 12:1999;19-27.
75. Hazen, S. L.; Gaut, J. P.; Crowley, J. R.; Hsu, F. F.; Heinecke, J. W. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions. Submitted; 2000.
76. Heller J.I., Crowley J.R., Hazen S.L., Salvay D.M., Wagner P., Pennathur S., Heinecke J.W. p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J. Biol. Chem. 275:2000;9957-9962.
77. Beauchamp R.O. Jr, Andjelkovich A., Kilgerman A.D., Morgan K.T., Heck H.D. A critical review of the literature on acrolein toxicity. CRC Crit. Rev. Toxicol. 14:1985;309-380.
78. Marnett L.J. Health effects of aldehydes and alcohols in mobile source emissions. Watson A.Y., Bates R.R., Kennedy D. Air pollution, the automobile and public health. 1988;579-603 National Academy Press, Washington, DC.
79. Rhodes J., Chen H., Hall S.R., Beesley J.E., Jenkins D.C., Collins P., Zheng B. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature. 377:1995;71-75.
80. McCormick M.L., Gaut J.P., Lin T.S., Britigan B.E., Buettner G.R., Heinecke J.W. Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase. J. Biol. Chem. 273:1998;32030-32037.
81. Jacob J.S., Cistola D.P., Hsu F.F., Muzaffar S., Mueller D.M., Hazen S.L., Heinecke J.W. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway. J. Biol. Chem. 271:1996;19950-19956.
82. Francis G.A., Mendez A.J., Bierman E.L., Heinecke J.W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl. Acad. Sci. USA. 90:1993;6631-6635.
83. Wang W.Q., Merriam D.L., Moses A.S., Francis G.A. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J. Biol. Chem. 273:1998;17391-17398.
84. Beckman J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler. 375:1994;81-88.
85. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield E.N., Parums D.V., Yacoub M.H., Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75:1996;77-85.
86. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233:1994;229-240.
87. Patel R.P., McAndrew J., Sellak H., White C.R., Jo H., Freeman B.A., Darley-Usmar V.M. Biological aspects of reactive nitrogen species. Biochim. Biophys. Acta. 1411:1999;385-400.
88. Eiserich J.P., Cross C.E., Jones A.D., Halliwell B., van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J. Biol. Chem. 271:1996;19199-19208.
89. Jiang Q., Hurst J.K. Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J. Biol. Chem. 272:1997;32767-32772.
90. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 330:1993;181-185.
91. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R., Hajjar D.P., Cohen P., Frazier W.A., Hoff H.F., Hazen S.L. The macrophage scavenger receptor CD36 is the major receptor for LDL recognition following modification by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105:2000;1095-1108.
92. Malech H.L., Nauseef W.M. Primary inherited defects in neutrophil function etiology and treatment . Semin. Hematol. 34:1997;279-290.
93. Aratani Y., Koyama H., Nyui S., Suzuki K., Kura F., Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67:1999;1828-1836.
94. Dakin H.D. The antiseptic action of hypochlorites, the ancient history of the "new antiseptic" Brit. Med. J. 2:1915;809.
95. Agner, K. Structure and function of oxidation-reduction enzymes. Akeson, A.; Ehrenberg, A., eds. Tarrytown, NY: Pergamon Press; 1972:329-335.